The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Lasting relief for frequent heartburn and acid reflux.
Always read the label and follow the directions for use.
Nexium 24HR 20 mg enteric coated tablets for the lasting symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux.
Always take this medicine exactly as described in the Consumer Medicine Information leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is one tablet a day. - Do not take more than this recommended dose of one tablet (20 mg) a day, even if you don't feel an improvement immediately. - You may need to take Nexium 24HR for a few days before experiencing the full effect. - Nexium 24HR should be taken for at least 7 days and up to 14 days. - Tell your pharmacist or doctor if you do not feel better while taking Nexium 24HR. If symptoms persist or recur within 2 weeks of completing the course, consult your doctor. Further examination may be required.
Always read the label, use only as directed. Tell your pharmacist or doctor if you notice any of the following and they worry you: nausea or vomiting, constipation, diarrhoea, headache, wind, stomach pain, skin rash, itchy skin, dizziness or dry mouth. These side effects are usually mild. Tell your pharmacist or doctor if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may interfere with Nexium 24HR. Do not take Nexium 24HR if you are pregnant unless your doctor says so. Ask your doctor about the risks and benefits involved. It is not known if it is safe for you to take Nexium 24HR while you are pregnant. It may affect your baby. Do not take Nexium 24HR if you are breastfeeding. Ask your doctor for more information. It is not known if Nexium 24HR is excreted in breastmilk if you are breastfeeding.
Xue HongwenCan you tell the difference between " Gastro-oesophageal Reflux Disease" and " Gastro- Esophageal Reflux Disease?"
Nexium 24HR contains simvoxetine, which belongs to a class of drugs called acid-regulating drugs. It works by reducing the amount of acid produced by the stomach and esophagus. This helps to treat frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux disease (OEC).
simvoxetine simvoxetine capsules Nexium 24HR is taken orally, usually once daily at the same time each day.
Take simvoxetine at least 1 hour before you take colchicine, antacids, multivitamins, multivitamins with calcium, supplements or laxatives such as Colchicine, Colchicine capsules, Colchicine tablets or Colchicine cream. Take colchicine at least 4 hours before or 6 hours after you take esomeprazole, a medicine used to treat bacterial gastro-oesophageal reflux disease (GORD). Nexium 24HR may also take theautions when you take this medicine because it may worsen your symptoms of OEC.
Take these symptoms seriously. They may come with warning signs such as:
As with all medication, inform your doctor about all the medicines, vitamins, supplements, drugs you are taking, including prescription and over-the-counter medicines, vitamins, and herbal products. Thischin and may also increase your risk of certain side effects.
Some medicines and Nexium 24HR may interact with each other.
The new deal will help $3.7 million in savings from the Nexium and Zantac coupons, the first two of which will end with an additional $6.3 million. If the coupons go through, Nexium and Zantac will be worth nearly $3.1 million, according to the Food and Drug Administration.
Nexium is the generic version of AstraZeneca's blockbuster cholesterol drug, which has lost patent protection in the past three years. But AstraZeneca executives are confident that the company will make $1.7 billion in savings in the future by using the drugs as part of a new program called Nexium Plus, which will be announced on Nov. 17. The combination will give the company a market share of about 7% of Nexium's total revenue.
Zantac and the $3.7 million Nexium coupon are both generic versions of the cholesterol drug, which Pfizer and other big drugmakers have been accused of using to treat heart disease. Pfizer, which acquired the rights to Nexium from AstraZeneca in 1997, has been accused of using the brand-name drug to make a profit off its generic drug, AstraZeneca Pharmaceuticals LP.
AstraZeneca executives have been trying to persuade the Food and Drug Administration to approve the generic version of the cholesterol drug. The FDA said the generic version of the drug will have a much smaller share of Nexium's market share, which would give the company more revenue.
The company's chief executive officer, Charles A. Evans, said in an interview that the company would work hard to get the drugs approved as part of the $3.7 million Nexium and Zantac savings deal, and it expects to achieve that goal by the end of the year. Evans also expects that the company will receive $6.3 million in savings from the savings programs.
The companies are looking at the long-term potential of the drugs and will decide whether to use them as a first-in-category deal. The companies are also considering options that will allow them to purchase Nexium from other manufacturers, which will be cheaper than the prices of the generic versions.
The company has been fighting a number of lawsuits against AstraZeneca for years, and its chief executive officer, Charles P. Evans, believes a similar deal could help to save up to $7.4 million a year. The company's most recent complaint is a lawsuit filed against Zantac by an individual named in the Nexium lawsuit. He is accused of selling a "slightly less expensive" version of the drug, the generic version, to doctors and hospitals for about $7 a tablet.
AstraZeneca said in a statement that it was aware of the litigation and that it would continue providing information and advice to other drugmakers.
Nexium is one of the most popular cholesterol medications worldwide, with roughly 10 million prescriptions written in the United States each year. The most common brand name cholesterol drug is Zetia, which is available in generic form as Zetia-Pills and other generic forms. AstraZeneca will pay for Nexium and Zetia to be sold at about the same prices as Zetia.AstraZeneca has had some success with its heart drug, Prevnar, which is also available as a generic drug and as a branded version of Pfizer's cholesterol drug Lipitor. The company has also been able to get Zetia to be marketed in the United States by generic versions, including by Lilly.
PPIAstraZeneca's largest drug company is the world's largest pharmaceutical company, with operations in more than 170 countries, including more than 2,500 locations around the world, according to a.PFIZER's chief executive officer, Richard Clarke, said in a statement that the company would continue to provide more information about the Nexium and Zantac savings programs.
Nexium has been the biggest moneymaker in the world since the drug's patent was assigned to a company that made $1.7 billion in sales in 2001. AstraZeneca has more than $1 billion in revenue and more than $6 billion of the $6.3 million Nexium coupon, depending on the deal. The company has had more than $1 billion in revenue for the past three years. (Source: FDA)Pfizer and AstraZeneca have been trying to get the companies to make a deal to use their drugs as part of a new program called Nexium Plus.
Nexium, known generically as esomeprazole, is a prescription medication used to treat various types of stomach acid. It belongs to a class of drugs known as proton pump inhibitors (PPIs).
It is used to treat conditions such as gastroesophageal reflux disease (GERD) and stomach ulcers caused by strict acid control. Esomeprazole works by decreasing the amount of stomach acid produced by the esophagus.
It does not treat the symptoms of ulcers. However, it is important to follow the recommended dosage and consult with a healthcare professional if you experience symptoms such as a sour stomach, heartburn, or difficulty swallowing.
Nexium is a type of medicine called an H2 blocker. It blocks the enzyme that breaks down a chemical called H2.
Nexium is an H2 blocker that is used to treat conditions such as:
It works by helping to reduce the amount of acid produced by the stomach.
The recommended dosage for Nexium is half a tablet of esomeprazole taken once daily.
However, it is important to follow the recommended dosage and consult with a healthcare professional if you experience stomach pain, difficulty swallowing, or persistent nausea or vomiting.
The recommended dosage for Vim is 40 mg once daily.
Vim is a proton pump inhibitor (PPI) that reduces the amount of acid produced by the stomach.
Vim works by decreasing the production of stomach acid.
Vim does not treat the symptoms of acid reflux.
Vim generally lasts a few days to a few weeks, depending on the condition being treated and other factors.
When used once a day, the medication is absorbed through the skin. Vim can be taken with or without food.
The dosage for Vim is usually lower in individuals with a history of acid reflux.
Vim can cause heartburn in some individuals. However, it is not a frequent side effect.
Vim does not cause frequent heartburn. It is important to talk to a healthcare professional if you experience persistent or severe heartburn.
Nexium, known generically as esomeprazole, is a prescription medication used to treat conditions such as:
oligorythritis
Contains wheat starchContraindications
Active Ingredients:Nexium 24HR Tablets:Each film-coated tablet contains 20 mg of esomeprazole. The active ingredient in Nexium 24HR is a proton pump inhibitor (PPI).
Manufacturer:Pfizer
Pfizer (New Zealand) is the leading exporter of generic medicines, pharmaceutical products, and dietary supplements. We deliver a safe and reliable service to all New Zealand customers.
Regulations:
Stade de France Pharmacy